Voyager Technologies
Government/defense cost-plus and fixed-price contract work plus space hardware/services, with a development-stage commercial space-station JV (Starlab) funded by NASA Space Act Agreements and partner capital. Revenue is backlog-driven program work, not recurring software.
The thesis on this name
State of Space & Launch
A newly-public (June 2025 IPO at ~$1.6B) space-and-defense name with three legs — Defense & National Security, Space Solutions, and the Starlab commercial space station — where the defense segment grew 63% in 2025 and management raised 2026 guidance to $225-255M on record $265.6M backlog, with Starlab commercial payload capacity already 130% subscribed (FY25/2026). Starlab is the call option on becoming an ISS-successor platform operator as the ISS retires; the defense leg funds the wait. Low conviction and small-weight because Starlab is years out, capital-intensive, and competitively contested (Vast, Axiom).
State of Space & Launch
Real station/defense story, but negative gross profit and ~-$91M FCF/quarter — the burn is too severe to own until a gross-margin-positive print.
Earnings, margins, COGS & capex
Voyager did $166.4M revenue in FY25 (+15% YoY) at a thin 17.9% gross margin, but Q1 FY26 revenue fell to $35.2M (-22.8% YoY, missing $36.1M consensus) and gross profit turned NEGATIVE at -$1.5M as cost of sales ($36.8M) exceeded revenue (fact). Operating loss widened to -$44.6M and FCF was -$66.8M in the quarter, against $429.4M cash and $641.4M liquidity with no material debt (fact). The bet rests on a record $275.3M backlog (+54% YoY) and a raised FY26 guide of $230–255M (+38–53%), implying a steep H2 ramp (fact; ramp dependence is the key estimate). The board's 'own only after a gross-margin-positive print' gate has not been met.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~100¢ is cost of goods and ~0¢ operating expense, and the remainder is an operating loss.
Revenue trend
Margins
down — turned negative (fact)
down — widening loss (fact)
down (fact)
down (fact/est)
deeply negative; magnitude varies by capex timing (fact)
COGS structure
COGS was $36.8M in Q1 FY26 vs $35.2M revenue — a negative gross profit. Cost structure is dominated by direct program execution: skilled engineering/technical labor, materials and specialized components for defense systems and space hardware, subcontractor content, and program overhead. As a contract/build prime (not a software business), gross margin is mix- and contract-type-dependent (cost-plus vs fixed-price); the negative Q1 print reflects an unfavorable revenue dip against a fixed cost base plus investment-stage programs that have not yet reached delivery scale — fact + analysis.
Capex
Cash burn is driven by R&D and capital investment ahead of revenue — Starlab development (the commercial ISS successor) plus defense program build-out and facilities. FY25 FCF of -$155.2M and Q1 FY26 FCF of -$66.8M (operating cash use -$39.7M) quantify the level; Starlab does not generate revenue today and is the primary multi-year cash sink — fact.
Latest earnings
Miss on both lines: revenue $35.2M vs $36.1M consensus; EPS -$0.75 vs -$0.59 estimate (worse) — fact.
RAISED FY26 revenue guide to $230–255M (+38–53% YoY) on record backlog, despite the Q1 miss — implies a heavy H2-weighted ramp (fact).
- Backlog (record)
- $275.3M, +54% YoY ($153.2M funded / $122.1M unfunded)
- Cash / liquidity
- $429.4M cash; $641.4M total incl. $212M revolver
- Free cash flow
- -$66.8M (op cash use -$39.7M)
- New bookings
- ~$45.2M in the quarter
Growth drivers
- Missile defense / Golden Dome programs of record — Standard Missile, Next Generation Interceptor work cited as Q1 win drivers (fact)
- Record backlog of $275.3M (+54% YoY), of which $153.2M funded — gives forward revenue visibility supporting the FY26 guide raise (fact)
- Defense & National Security segment — grew 59% in FY25 to $123.0M and is the cash-generative engine (fact)
- Named contract wins with Anduril and across multiple defense programs of record (fact)
- Starlab commercial space station — long-dated optionality; management projects >$4B annual revenue / ~$1.5B annual FCF once operational (management estimate, not near-term — flag as aspirational)
- Post-ISS commercial LEO transition — NASA CLD/free-flyer program funding the destination market Starlab targets (fact)
Reported financials — SEC EDGAR
Audited GAAP figures pulled from SEC filings · latest filing 2026-03-10. The audited primary-source spine — not financial advice.
Revenue — annual (GAAP)
Margins & balance sheet — FY’25
Bull & bear
VOYG is a backlog-rich defense-and-space prime with a fortress balance sheet and a NASA-funded call option (Starlab) on the entire post-ISS commercial-station market; if the H2 ramp converts backlog and gross margin turns positive, the optionality is materially undervalued at a ~$1.8B cap.
- Record $275.3M backlog (+54% YoY, $153.2M funded) underwrites the raised $230–255M FY26 guide — visibility most micro/small-caps lack (fact)
- Defense & National Security is structurally growing (+59% FY25) into a Golden Dome / missile-defense super-cycle with named programs of record (fact)
- $429.4M cash / $641.4M liquidity, no real debt — runway to fund the burn for ~2+ years without forced dilution (fact)
- Starlab is a real, partner-backed (Airbus/Mitsubishi/MDA), NASA-funded seat in a market created by the ~2030 ISS deorbit — asymmetric upside if it lands (fact)
- Stock is ~44% off its 52-week high ($52.40 → $29.32), so much of the burn is already discounted (fact)
The work itself loses money — negative gross profit plus ~-$67M to -$91M FCF/quarter on $35M revenue — and the entire thesis hinges on an unproven H2 ramp and a pre-revenue, multi-year Starlab; until a gross-margin-positive print arrives, this is a burn-rate story to avoid, exactly per the board's gate.
- Gross profit went NEGATIVE (-$1.5M, Q1 FY26): VOYG loses money before opex, the explicit disqualifier — no margin of safety in the unit economics (fact)
- Revenue fell 22.8% YoY and missed, yet guidance was raised — the bull case is entirely a back-half ramp that has not been demonstrated (fact)
- FCF of ~-$67M to -$91M/quarter burns ~$270M+ annualized against $429M cash — the clock is running, dilution risk is real if the ramp slips (fact/analysis)
- Starlab is years from revenue and depends on NASA appropriations + SpaceX Starship schedule — two exogenous risks outside management control (fact)
- Crowded commercial-station field (Axiom, Vast, Orbital Reef, SpaceX) means even a successful Starlab faces price/seat competition (analysis)
What it is worth
Sum-of-the-parts: (1) defense/space operating business on EV/sales given negative margins, plus (2) a risk-weighted option value on Starlab — not earnings-based (company is deeply loss-making). At ~$1.8B market cap and net cash of ~$429M, EV is ~$1.4B, or ~6x FY26 guided sales ($230–255M).
$17 or below (52-wk low $17.41)
if the ramp slips, burn forces dilution, or Starlab funding/timeline deteriorates
~$29 (current)
market holding for proof of the H2 ramp and a margin inflection; EV ~6x guided sales
$50+ (toward prior 52-wk high)
if gross margin turns positive, FY26 ramp lands at the high end, and Starlab funding/schedule de-risks
A deep-loss, optionality-driven name: the multiple is paying for Starlab + defense growth, not current profit — re-rates only on a gross-margin-positive print and H2 ramp proof.
SWOT
Strengths
- Net-cash balance sheet — $429.4M cash and $641.4M liquidity with no material debt funds the burn for multiple years (fact)
- Defense & National Security momentum — segment +59% in FY25 to $123.0M, anchored to Golden Dome / missile-defense programs of record (fact)
- Record $275.3M backlog (+54% YoY) gives unusual forward visibility for a sub-scale name (fact)
- Starlab gives a credible, NASA-funded seat in the post-ISS commercial-station market most peers cannot match (fact)
- Blue-chip JV partners (Airbus, Mitsubishi, MDA Space) de-risk Starlab technical execution and capital (fact)
Weaknesses
- Negative gross profit (-$1.5M in Q1 FY26) — the company loses money on the work itself before opex, the board's explicit disqualifier (fact)
- Severe cash burn — ~-$67M to -$91M FCF/quarter against $35M revenue is unsustainable without the ramp (fact)
- Q1 revenue fell 22.8% YoY and missed — guidance raise rests entirely on an unproven H2 ramp (fact)
- Lumpy, contract-driven revenue with low margin visibility (cost-plus vs fixed-price mix) (analysis)
- Starlab is pre-revenue and capital-hungry for years before any return (fact)
Opportunities
- ISS deorbit ~2030 creates a forced multi-billion-dollar commercial LEO destination market Starlab is positioned for (fact)
- Golden Dome / missile-defense budget surge — multiple new programs of record cited as Q1 demand drivers (fact)
- Funded backlog conversion + new bookings can push the gross margin back positive at higher volume (analysis)
- Defense-tech tailwind and partnerships (Anduril) expand addressable national-security work (fact)
- Starlab management TAM — >$4B annual revenue / ~$1.5B FCF if operational — large optionality if it lands (management estimate)
Threats
- NASA budget / CLD program risk — Starlab funding and the post-ISS timeline depend on appropriations that can slip or be cut (fact)
- Launch dependence on SpaceX Starship (single-launch Starlab) — schedule slips cascade (fact)
- Well-capitalized competitors (Axiom, Vast, Blue Origin Orbital Reef, SpaceX) racing for the same commercial-station seats (fact)
- Equity dilution / capital-raise risk if the ramp slips and cash erodes (analysis)
- Defense procurement cyclicality and contract-award timing volatility (analysis)
Moats, dependencies & bottlenecks
Moats
NASA Space Act Agreement + CLD position for Starlab (>$217M awarded) tied to appropriations and program continuity through ~2030 Government-funded seat in the post-ISS market is hard to replicate but politically/budget contingent — fact
security clearances and incumbency on programs of record are sticky Anchors the Defense & National Security segment; high switching cost for the customer — analysis
partner capital + tech depth competitors must assemble Consortium is a barrier but partners could also back rivals over time — fact
backlog converts but is re-competed at renewal $275.3M backlog gives visibility, not pricing power — fact
Sub-scale vs SpaceX/Blue Origin/Lockheed; no cost or network advantage — analysis
Dependencies
NASA funding (CLD / Space Act Agreement / Commercial Destinations Free Flyer) Starlab's development funding and the post-ISS timeline ride on federal appropriations that can slip or be cut — fact
Standard Missile, NGI) Defense segment is the cash engine; concentrated in government budgets and award timing — fact
Single-launch architecture depends on Starship reaching cadence/readiness — a competitor also launches it — fact
Starlab design/build and co-funding depend on partner commitment continuing — fact
Burn of ~$270M+/yr means access to capital matters if the ramp slips before margins turn — analysis
Advantages
- Net-cash, no-debt balance sheet ($429.4M cash / $641.4M liquidity) — rare for a cash-burning small-cap (fact)
- Record $275.3M backlog (+54% YoY) gives forward revenue visibility (fact)
- Incumbency + clearances on national-security programs of record (Golden Dome, missile defense) (fact)
- NASA-funded Starlab seat in the post-ISS market — a credible large optionality few peers hold (fact)
- Marquee partners (Airbus/Mitsubishi/MDA) and customers (Anduril, DoD, NASA) lend technical and commercial credibility (fact)
Weaknesses
- Negative gross profit (-$1.5M, Q1 FY26) — loses money on the work itself (fact)
- Severe FCF burn (~-$67M to -$91M/quarter) far exceeding revenue (fact)
- Q1 revenue -22.8% YoY and a consensus miss — execution/visibility risk (fact)
- Lumpy contract revenue with thin, mix-dependent margins (analysis)
- Starlab is pre-revenue and a multi-year capital sink with binary outcomes (fact)
- Sub-scale vs the dominant space/defense primes — no cost or scale moat (analysis)
Bottlenecks
- Gross margin — the binding constraint: until COGS falls below revenue at scale, every dollar of growth deepens the loss (fact)
- Backlog-to-revenue conversion timing — the H2-weighted ramp must materialize for the raised guide to hold (fact)
- Starlab schedule gated by SpaceX Starship readiness and the ~2030 ISS deorbit window (fact)
- Cash runway vs burn — ~$429M cash against ~$270M+/yr burn caps how long the ramp can take before a raise (analysis)
- Skilled aerospace/cleared-engineering labor and specialized supply chain for program execution (analysis)
- NASA appropriations cadence for CLD development (~$272M FY26 PBR; ~$2.1B/5yr) (fact)
Top signals & trends
Top signals
The board's explicit own-it trigger; turns the thesis from burn-story to value-story — watch Q2/Q3 FY26 (fact)
Backlog conversion must accelerate sharply after a -22.8% Q1; the guide is back-half loaded (fact)
If burn stays ~-$70M+/qtr without a margin turn, a dilutive raise becomes likely — watch runway (analysis)
$45.2M Q1 bookings; further programs of record extend the cash-engine backlog (fact)
Funding continuity and Starship launch readiness gate the optionality — both exogenous (fact)
Fresh partner or external Starlab capital would offload burn from the parent balance sheet (analysis)
Trends
Creates the multi-billion-dollar market Starlab targets; NASA is funding the handoff (fact)
Drove Q1 defense bookings and the FY25 +59% segment growth (fact)
Stock down ~44% from 52-wk high; market is penalizing burn until margins turn (fact)
Axiom, Vast, Orbital Reef, SpaceX all chasing the same post-ISS seats (fact)
Expands national-security addressable work for VOYG (fact)
Enables single-launch Starlab but ties its schedule to a third party's cadence (fact)
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Launch vehicle for single-launch Starlab; also builds NASA's ISS deorbit vehicle — supplier and rival
Starlab JV partner — design/technical support and co-funding (Airbus is EADSY ADR)
Starlab JV partner — capital and commercialization in Asia
Starlab JV partner — robotics/space systems (TSX:MDA)
Specialized aerospace component & materials vendors Direct program inputs driving COGS for defense and space hardware
Anchor customer/funder — Space Act Agreement (>$217M) + CLD program for Starlab; ISS-successor buyer
US Department of Defense / Missile Defense Agency Buyer of Golden Dome, Standard Missile, Next Generation Interceptor work — the cash engine
Defense-tech partner/customer named in Q1 wins (private)
Classified Defense & National Security program customers
Pharma, research, sovereign astronauts — Starlab's eventual revenue base (pre-revenue today)
Prime competitor in missile defense / national-security systems; former Starlab partner now displaced by Airbus — outscales VOYG massively
Private — most direct commercial-station rival to Starlab; already flying private ISS missions ahead of its free-flyer
Private — Haven-1/Haven-2 commercial stations launching on SpaceX; aggressive timeline competitor for CLD seats
Private (Bezos-funded) — Orbital Reef commercial station with Sierra Space; deep-pocketed rival
Listed space-infrastructure / in-space manufacturing peer; overlaps on space hardware and components
Listed space prime (launch + space systems); broader, scaling faster, overlaps on space solutions